NEW YORK and TEL AVIV, Israel, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Nukkleus Inc. (NASDAQ: NUKK), a strategic acquirer and developer of high-potential businesses in the Aerospace and Defense (A&D) sector ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Jan 6 (Reuters) - Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly (LLY.N), opens new tab to develop artificial intelligence-driven ...
Boston biotech Nimbus Therapeutics is teaming up with Eli Lilly & Co. to develop a new oral obesity treatment in a deal worth up to $1.3 billion, the company announced Tuesday. It’s the latest move in ...
Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...
For a second time, Eli Lilly has turned to Boston biotech Nimbus Therapeutics to add a potential weight loss therapy to its pipeline. The latest agreement, which could be worth upwards of $1.3 billion ...
The next evolution of Asics’ enduring Gel-Nimbus running franchise is just around the corner. Asics touts the Gel-Nimbus 28 as being 20 grams lighter than its predecessor, the Gel-Nimbus 27. This is ...
Add Yahoo as a preferred source to see more of our stories on Google. Do you ever look at your animals and wonder if they'll ever help with rent? Or are they just destined to remain the cute little ...
Do you ever look at your animals and wonder if they'll ever help with rent? Or are they just destined to remain the cute little monsters who sleep, snack, and contribute absolutely nothing besides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results